The seventh edition of Pharmaceutical Trademarks: A Global Guide, which provides trademark professionals with comprehensive guidance on the key issues involved in the protection, enforcement and marketing of pharmaceutical brands, is now available to view online.

In its Pharma 2020 series, PwC estimated that the global pharmaceutical market could be worth nearly $1.6 trillion by 2020. While strong brands are a key business asset in all industry sectors, in the increasingly competitive pharmaceutical world they are truly critical for long-term success, offering product protection that extends far beyond the lifecycle of patent protection. However, practitioners tasked with the development, registration, protection, commercial exploitation and marketing of pharmaceutical brands are faced with a complex web of legal and regulatory requirements, with the picture varying significantly from jurisdiction to jurisdiction.

With local know-how paramount, Pharmaceutical Trademarks: A Global Guide has firmly established itself as the ‘go to’ resource for trademark professionals seeking  comprehensive guidance on the critical issues involved in the protection, enforcement and marketing of pharmaceutical brands. Written by experts from leading firms around the globe, the guide is designed to be a simple, user-friendly digest of the main issues faced by those charged with developing and safeguarding these key assets, providing an easily accessible international comparison of the respective practices and procedures governing pharmaceutical marks.

To that end, this latest edition provides in-depth guidance on the legal regime in 12 key jurisdictions, as well as insight into how to manage a pharmaceutical trademark portfolio with the assistance of outside counsel.

Hard copies of the supplement will be mailed to World Trademark Review subscribers shortly and, in the meantime, the latest edition of the publication is live for all to view here.

Trevor Little

  • Author
  • Editor

Comments

Please log in or register to leave a comment.

There are no comments on this article

Share this article